Nipro To Snap Up Home Diagnostics For $215M

By Erin Marie Daly

Law360, New York (February 03, 2010, 12:48 PM ET) -- Nipro Corp. revealed Wednesday that it was set to fork out $215 million to acquire diabetes testing supply maker Home Diagnostics Inc., a move that will allow the Japanese medical device manufacturer to launch its pump products in the U.S. market.

The two companies said they had signed a definitive merger agreement under which Nipro will acquire all outstanding shares of Home Diagnostics’ common stock for a cash purchase price of $11.50 per share.

The offer price represents an approximately 90 percent premium to the closing...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles